Featuring an immersive, cinematic, and ever-evolving story, ArcheAge Chronicles combines a rich, expansive and persistent world with the thrilling, fast-paced elements of an online Action/RPG. Explore ...

Is the Turing test still relevant in today's AI landscape? The advent of large language models has challenged its importance. When you purchase through links on our site, we may earn an affiliate ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

One of the industry’s leading large language models has passed a Turing test, a longstanding barometer for human-like intelligence. In a new preprint study awaiting peer review, researchers report ...

As the nation experiences what many experts believe is the second-largest wave of COVID infections since the pandemic started, many Americans will be checking to make sure they don’t have the ...

Featuring an immersive, cinematic, and ever-evolving story, ArcheAge Chronicles combines a rich, expansive and persistent world with the thrilling, fast-paced elements of an online Action/RPG. Explore ...

Test anxiety is something many students struggle with, but it’s often misunderstood. Most people think it’s caused by the pressure of limited time, tough material, or high expectations. However, as ...

ArcheAge Chronicles is developer XL Games' upcoming sequel to its 2013 MMO ArcheAge, as revealed during last night's PlayStation State of Play event - and it sounds even bigger than the original.

Unveiling 'ArcheAge Chronicles': Dive into a new era with ArcheAge Chronicles, the online action RPG set 50 years after the original. Embark on epic adventures, engage in enhanced combat, and explore ...

July 29 (Reuters) - Guardant Health (GH.O), opens new tab said its blood test to detect cancer that starts in the colon or rectum got an approval from the U.S. Food and Drug Administration, with the ...

The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer. The test isn't meant to replace colonoscopies, but is generating enthusiasm ...

While not a perfect alternative to colonoscopies, experts hope the test could lead to more people getting screened for colorectal cancers. By Gina Kolata The Food and Drug Administration on Monday ...